Ding Lili, Liu Mengru, Sun Haijun
Suqian First Hospital, Department of Critical Care Medicine, Suqian, China.
J Med Biochem. 2025 Mar 21;44(2):319-329. doi: 10.5937/jomb0-53853.
Sepsis/septic shock is a life-threatening condition that requires prompt and effective treatment. Noradrenaline is a widely used vasopressor to manage septic shock, but its optimal dosage remains unclear. This study aimed to investigate the effects of noradrenaline doses on the prognosis of patients with sepsis/septic shock and identify the influencing factors for patient survival.
A retrospective study was conducted on 126 patients with sepsis/septic shock who received noradrenaline treatment in the intensive care unit (ICU). Patients were divided into survival (n=91) and death (n=35) groups. Clinical data, laboratory results, and noradrenaline doses were collected and compared between the two groups.
脓毒症/脓毒性休克是一种危及生命的病症,需要迅速且有效的治疗。去甲肾上腺素是用于治疗脓毒性休克的一种广泛使用的血管加压药,但其最佳剂量仍不明确。本研究旨在探讨去甲肾上腺素剂量对脓毒症/脓毒性休克患者预后的影响,并确定影响患者生存的因素。
对126例在重症监护病房(ICU)接受去甲肾上腺素治疗的脓毒症/脓毒性休克患者进行了一项回顾性研究。患者被分为生存组(n = 91)和死亡组(n = 35)。收集并比较两组患者的临床资料、实验室检查结果及去甲肾上腺素剂量。